Funder
National Cancer Institute
National Institutes of Health
Reference65 articles.
1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012
2. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J Clin Oncol,2010
3. Immunotherapies for non-small-cell lung cancer and mesothelioma;Thomas;Lancet Oncol,2012
4. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome;Shepherd;J Thorac Oncol,2011
5. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献